68 related articles for article (PubMed ID: 15869458)
21. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine].
Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H
Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079
[TBL] [Abstract][Full Text] [Related]
22. Nuclear imaging of solid hepatic masses.
Kinnard MF; Alavi A; Rubin RA; Lichtenstein GR
Semin Roentgenol; 1995 Oct; 30(4):375-95. PubMed ID: 8539646
[TBL] [Abstract][Full Text] [Related]
23. [Scintigraphic localization of neuroendocrine tumors and their metastases using a somatostatin analog [111In-DTPA-d-phe1] octreotide].
Beckers A; Pham VT; Abs R; Foidart-Willems J; Meurisse M
Rev Med Liege; 1993 Jun; 48(6):326-34. PubMed ID: 8101999
[No Abstract] [Full Text] [Related]
24. Scintigraphic imaging of sarcomatous tumors with [(111)In-DTPA-phe-1]-octreotide.
Giannakenas C; Kalofonos HP; Apostolopoulos D; Petsas T; Kalogeropoulou C; Tzorakelefterakis E; Skopa CD; Vassilakos PJ
Oncology; 2000; 58(1):18-24. PubMed ID: 10644936
[TBL] [Abstract][Full Text] [Related]
25. Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.
Gulec SA; Drouant GJ; Fuselier J; Anthony CT; Heneghan J; DelCarpio JB; Coy DH; Murphy WA; Woltering EA
J Surg Res; 2001 May; 97(2):131-7. PubMed ID: 11341788
[TBL] [Abstract][Full Text] [Related]
26. Detection of multiple hepatic metastases of gastrinoma not apparent on CT by In-111 octerotide scintigraphy.
McInerney GF; Carmalt H; MaGee M; Allman K; van der Wall H
Clin Nucl Med; 1996 Sep; 21(9):730-1. PubMed ID: 8879876
[No Abstract] [Full Text] [Related]
27. Emerging roles for radiometabolic therapy of tumors based on auger electron emission.
Mariani G; Bodei L; Adelstein SJ; Kassis AI
J Nucl Med; 2000 Sep; 41(9):1519-21. PubMed ID: 10994732
[No Abstract] [Full Text] [Related]
28. Intraoperative hand held gamma probe detection of a recurrent nonfunctional neuroendocrine tumor.
Van Haren RM; Fitzgerald TL
JOP; 2008 Nov; 9(6):704-7. PubMed ID: 18981551
[TBL] [Abstract][Full Text] [Related]
29. In-111 pentatreotide uptake in a chondrosarcoma.
Baxter KG; Rosenthal HG; Redick ML; Preston D
Clin Nucl Med; 1996 Dec; 21(12):1008-9. PubMed ID: 8957636
[No Abstract] [Full Text] [Related]
30. Octreotide scintigraphy in the detection of recurrent paragangliomas.
Bustillo A; Telischi FF
Otolaryngol Head Neck Surg; 2004 Apr; 130(4):479-82. PubMed ID: 15100648
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine differentiated breast carcinoma with pleural metastases using indium-111 octreotide.
Suchak AA; Millo N; MacEwan R; McEwan AJ
Clin Nucl Med; 2009 Feb; 34(2):74-5. PubMed ID: 19352254
[No Abstract] [Full Text] [Related]
32. Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan.
Lin JC; Palafox BA; Jackson HA; Cohen AJ; Gazzaniga AB
Ann Thorac Surg; 1999 Feb; 67(2):555-8. PubMed ID: 10197697
[TBL] [Abstract][Full Text] [Related]
33. Advances in radio-imaging of neuroendocrine tumors.
Vekemans MC; Urbain JL; Charkes D
Curr Opin Oncol; 1995 Jan; 7(1):63-7. PubMed ID: 7696365
[TBL] [Abstract][Full Text] [Related]
34. Ga-67 and In-111 pentreotide imaging.
Spieth ME; Vasinrapee P
Clin Nucl Med; 1996 Jan; 21(1):80. PubMed ID: 8741905
[No Abstract] [Full Text] [Related]
35. Neuroendocrine liver metastases - 'doughnut box sign' on SPECT/CT.
Thomson N; Pina C; Bashir H; Ellul G
J Pak Med Assoc; 2022 Dec; 72(12):2571-2572. PubMed ID: 37246696
[TBL] [Abstract][Full Text] [Related]
36. Production and quality control of [(90)Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 syntheses.
Biasiotto G; Bertagna F; Zanella I; Biasiotto U; Savelli G; Caimi L; Bettinsoli G; Giubbini R; Chinol M
Nucl Med Commun; 2013 Mar; 34(3):265-70. PubMed ID: 23276826
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of In-111 Octreotide in brain infarcts: a case report.
Miron SD; Markowitz D; Minotti A
Clin Nucl Med; 1998 Mar; 23(3):163-4. PubMed ID: 9509931
[TBL] [Abstract][Full Text] [Related]
38. Imaging in thyroid-associated orbitopathy.
Kahaly GJ
Eur J Endocrinol; 2001 Aug; 145(2):107-18. PubMed ID: 11454505
[No Abstract] [Full Text] [Related]
39. NDA sought for cancer imaging radiolabeled peptide.
J Nucl Med; 1993 Jan; 34(1):24N. PubMed ID: 8418266
[No Abstract] [Full Text] [Related]
40. First peptide agent enters clinical arena.
Brice J
Diagn Imaging (San Franc); 1994 Jul; 16(7):83. PubMed ID: 10184171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
